Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-06-15 Sale | 2023-06-20 4:25 pm | Revance Therapeutics Inc. | RVNC | Kolaja Carey OConnor Director | 2,500 | $28.24 | $70,600 | 24,817 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-05-01 Option Award | 2024-05-03 08:45 am | N/A 2034-04-30 | Revance Therapeutics Inc. | RVNC | Kolaja Carey OConnor Director | 38,458 | $0 | 55,019 (Direct) | View |
2023-06-15 Exercise | 2023-06-20 4:25 pm | N/A 2032-05-03 | Revance Therapeutics Inc. | RVNC | Kolaja Carey OConnor Director | 2,500 | $0 | 24,817 (Direct) | View |
2023-06-15 Exercise | 2023-06-20 4:25 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Kolaja Carey OConnor Director | 2,500 | $18.12 | 24,817 (Direct) | View |
2023-05-03 Option Award | 2023-05-05 5:14 pm | N/A 2033-05-02 | Revance Therapeutics Inc. | RVNC | Kolaja Carey OConnor Director | 9,449 | $0 | 22,476 (Direct) | View |
2022-05-04 Option Award(A) | 2022-05-13 6:10 pm | N/A 2032-05-03 | Revance Therapeutics Inc. | RVNC | Kolaja Carey OConnor Director | 10,756 | $0 | 10,756 (Direct) | View |
2022-05-04 Option Award | 2022-05-06 6:19 pm | N/A 2032-05-03 | Revance Therapeutics Inc. | RVNC | Kolaja Carey OConnor Director | 17,402 | $0 | 24,370 (Direct) | View |
2021-05-05 Option Award | 2021-05-07 7:08 pm | N/A 2031-05-04 | Revance Therapeutics Inc. | RVNC | Kolaja Carey OConnor Director | 1,942 | $0 | 8,236 (Direct) | View |
2021-03-01 Option Award | 2021-03-02 8:17 pm | N/A 2031-02-28 | Revance Therapeutics Inc. | RVNC | Kolaja Carey OConnor Director | 17,711 | $0 | 17,711 (Direct) | View |